project id: TCGA-PRAD; case submitter id: TCGA-HC-A4ZV; source center: 23; state: released; a260 a280 ratio: 1.89; age at index: 56; days to birth: -20634; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1956; age at diagnosis: 20634; ajcc clinical t: T2c; ajcc pathologic n: N0; ajcc pathologic t: T3b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 23.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 5; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 4; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; days to collection: 79; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-HC-A4ZV-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 80.0;